Resources

Webinars

Post-Grant for Practitioners: A bi-monthly series of webinars focusing on developments in post-grant proceedings and related practice tips.

Fish & Richardson is the most active firm in post-grant proceedings at the PTAB. In 2012, we kicked-off a webinar series designed to share practice tips, nuances, observations, and strategy. Recordings for previous webinars in this series are included below, with the most recent appearing first.

WEBINAR ARCHIVES:   2018  |  2017  |  2016  |  2015  |  2014  |  2013  |  2012

2019 Webinar Series

August 21, 2019

Post-Grant for Practitioners: Updates to the AIA Trial Practice Guide

On July 15, 2019, the USPTO published its second update to the AIA Trial Practice Guide. This update primarily incorporates decisions that the PTAB has designated as precedential since the first update in August 2018, and it covers a wide variety of topics ranging from the filing of a petition to the reopening of proceedings following remand from the Federal Circuit. Join Fish Principal David Holt and Associate Kenneth Darby for our latest Post-Grant for Practitioners webinar, where our hosts will take a deep dive into these topics and more, including: 

  • Claim construction
  • Patent owner preliminary responses
  • Discretionary trial institution

Register today!

Speakers:
David Holt
Kenneth Darby



June 27, 2019

Biosimilars – 2019 Mid-Year Update

On July 18, please join life sciences attorneys John Adkisson, Tasha Francis, and Jenny Shmuel, who will provide a mid-year review on the current status of the U.S. biosimilars space. Topics to be discussed include recent developments regarding:

  • The U.S. biosimilars market: approvals, launches, and anticipated launches
  • FDA guidance
  • Select court cases and appellate guidance
  • Trends in IPRs in the biosimilars space
  • What’s on the horizon for biosimilars

Recent legislative proposals with potential impact on the biosimilars market will also be reviewed. Be sure to register at the link below to remain current on developments in the rapidly-evolving U.S. biosimilars market.

Thursday, July 18
1:00-2:00 PM EDT

This program is designed for and open to all attorneys. If you have questions, please contact Jane Lundberg at lundberg@fr.com.

Fish & Richardson, P.C., is an accredited CLE provider by the California, New York, and Texas State Continuing Legal Education Boards. (California Provider Number 4933) Fish & Richardson will apply for 1.0 hour of CLE credit in some additional states. Credit will be awarded only to attorneys who report their required CLE states during the registration process and who log in and complete the webinar in its entirety. Note that Fish is unable to grant CLE credit to attendees who listen to the audio portion only.




June 13, 2019

Post-Grant for Practitioners – NHK, Valve, and Discretionary Denial

The PTAB recently designated two decisions as precedential that expanded the factors upon which it may rely when exercising its discretion to deny IPR petitions under §§ 314(a) and 325(d). In NHK Spring v. Intri-Plex, the PTAB held that the Board may consider the status of co-pending district court litigation when evaluating whether to institute IPR proceedings. In Valve Corp. v. Electronic Scripting Products, the PTAB held that the General Plastic factors permit the Board to deny follow-on petitions even when filed by different petitioners where the petitioners are closely related or similarly situated.

In this Post-Grant for Practitioners Webinar, Principal and Post-Grant Practice Co-Chair Karl Renner, Principal Joshua Griswold, and Associate Kenneth Darby discuss these cases and their implications, including:

  • In-depth analysis of the NHK and Valve decisions
  • Trends and takeaways from other recent § 314(a) discretionary denials
  • Strategic and tactical considerations for petitioners and patent owners
Speakers:
Karl Renner
Joshua Griswold
Kenneth Darby
May 8, 2019

Post-Grant for Practitioners – SAS and Oil States: One Year Later

In April of 2018, the Supreme Court issued its much-anticipated decisions in Oil States Energy Services, LLC v. Greene’s Energy Group, LLC and SAS Institute, Inc. v. Iancu, both of which have had significant impacts on post-grant practice. In Oil States, the Court upheld the constitutionality of IPR proceedings under the public rights doctrine. In SAS Institute, the Court ended the PTAB’s practice of partial institution, holding that it must institute IPR proceedings either on all of the challenged claims or none of the challenged claims. 

At the one year anniversary of these decisions, Fish Principals Dorothy Whelan, Karl Renner, and Rob Courtney look back over the previous year and discuss how these cases have changed post-grant practice. Topics of discussion include: 

  • The implications of SAS for post-grant estoppel (and beyond)
  • Lingering questions left unanswered by the “narrow” holding of Oil States
  • Strategic considerations for petitioners and patent owners
Speakers:
Dorothy Whelan
Karl Renner
Rob Courtney
March 27, 2019

Hatch-Waxman and IPR Strategy

Inter partes review (IPR) proceedings have become an attractive option for generic drug manufacturers wishing to utilize the PTAB’s streamlined patent validity decision process while also reaping the benefits of the Hatch-Waxman Act. However, many believe that allowing generics to apply both of these strategies disrupts the balance between encouraging pharmaceutical innovation and lowering drug prices that the Hatch-Waxman Act intended to preserve. This debate has escalated since the Hatch-Waxman Integrity Act of 2018, which seeks to force generics to choose between the Hatch-Waxman framework and IPR.

In this webinar, Principal and Post-Grant Practice Co-Chair Dorothy Whelan and Principal Chad Shear address these complex issues and more, including:

  • IPR basics and how they apply to Hatch-Waxman cases
  • The “who, when, and where” of IPR filings and the decisions that go into filing
  • Recent decisions and arguments impacting Hatch-Waxman and IPR strategy
Speakers:
Dorothy Whelan
Chad Shear
January 17, 2019

2018 Biosimilars – A Year in Review

The U.S. biologics and biosimilars markets evolved rapidly in 2018. In this webinar, life sciences attorneys John Adkisson, Tasha Francis, and Jenny Shmuel review the U.S. market for biosimilar products and provide insights into:

  • Which biosimilars have been approved and launched
  • Recent regulatory and legislative actions impacting the biosimilars market
  • Select court cases and settlements
  • Recent trends in IPR filings in the biosimilars space
  • What to look forward to in 2019
Speakers:
John Adkisson
Tasha Francis
Jenny Shmuel
January 9, 2019

Post-Grant for Practitioners: 2018 Year in Review

2018 was a watershed year for PTAB practitioners. The Supreme Court of the United States (SCOTUS) and the Court of Appeals for the Federal Circuit (CAFC) issued several important decisions relating to the constitutionality of post-grant practice itself, RPI/privity, partial institution decisions, and printed publications. In addition, the PTAB adopted new claim construction rules replacing BRI with the Philips standard, and proposed a new pilot procedure for claim amendments. Changes to the trial practice guide included patent owner surreplies as a matter of right and institution standards governing multiple petitions/petitioners.

In this webinar, Fish Principals and Post-Grant Practice Co-Chairs Dorothy Whelan and Karl Renner took a closer look at these significant developments and examined their impact on practitioners. Dorothy and Karl discussed:

  • PTAB Statistics and Trends
  • Decisions and Case Law Developments at the PTAB, CAFC, and SCOTUS, including:
    • Oil States Energy Services, LLC v. Greene’s Energy Group, LLC
    • SAS Institute, Inc. v. Iancu
    • Applications in Internet Time, LLC v. RPX Corp.
    • Click-to-Call Technologies, LP v. Ingenio, Inc.
    • General Plastic Industrial Co., Ltd. v. Canon Kabushiki Kaisha (Board Discretion: 314, 325)
    • GoPro, Inc. v. Contour IP Holding, LLC
  • What to Watch For in 2019
Speakers:
Karl Renner
Dorothy Whelan

Fill out the form below to receive our monthly newsletter and updates on your selected areas of interest. You can unsubscribe at any time by clicking the unsubscribe link at the bottom of the email.

  • Fish & Richardson P.C. is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the services you requested from us. From time to time, we would like to contact you about our services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below.
  • In order to provide you the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please tick the checkbox below.
  • You can unsubscribe from these communications at any time. This can be done by clicking the unsubscribe link at the bottom of marketing emails you receive from us, or by emailing info@fr.com stating that you would like to be unsubscribed.
  • This field is for validation purposes and should be left unchanged.